N-bromotaurine

01/01/2005 - "Is there a role of taurine bromamine in inflammation? "
01/01/2016 - "Then, aided by this tool, we evaluated the ability of N-bromotaurine, a naturally occurring, small-molecule, nonsteroid anti-inflammatory drug which is under consideration for use interchangeably/in replacement to GCs in skin inflammations, to restore antiproliferative response of GC-resistant cancer cells. "
08/24/2010 - "This review is an attempt to summarize our knowledge about taurine bromamine (TauBr) properties, its role in innate immunity and its therapeutic potential.TauBr and taurine chloramine (TauCl) are major haloamines generated by eosinophils and neutrophils at a site of inflammation. "
01/01/2014 - "Upon inflammation, taurine undergoes halogenation in phagocytes and is converted to taurine chloramine (TauCl) and taurine bromamine. "

01/07/2021 - "Both N-bromotaurine (TauNHBr) and BAT exert potent anti-inflammatory properties, but the landscape remains obscure concerning the anti-cancer effect of BAT. "
01/01/2016 - "Then, aided by this tool, we evaluated the ability of N-bromotaurine, a naturally occurring, small-molecule, nonsteroid anti-inflammatory drug which is under consideration for use interchangeably/in replacement to GCs in skin inflammations, to restore antiproliferative response of GC-resistant cancer cells. "
01/01/2016 - "Unlike GCs, N-bromotaurine inhibited cell-cycle progression in GC-resistant cancer cells and efficiently synergized with cisplatin, thus indicating a potential to be exploited instead of GCs against cancer."
01/01/2016 - "N-bromotaurine surrogates for loss of antiproliferative response and enhances cisplatin efficacy in cancer cells with impaired glucocorticoid receptor."
10/01/2008 - "In squamous cell carcinomas of the skin, ovarian cancers, lymphomas, Hodgkin's disease, and breast cancers, low (.)NO concentrations arise from the inhibition of iNOS by N-bromotaurine, produced by eosinophil-peroxidase-expressing infiltrating eosinophils. "

07/01/2008 - "Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study."
01/01/2006 - "Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris."

10/01/2009 - "Taurine bromamine: a new therapeutic option in inflammatory skin diseases."

01/01/2022 - "Taurine and N-Bromotaurine in Topical Treatment of Psoriasis."